Cite
Pharmacokinetics, efficacy, and safety of mycophenolate mofetil in combination with standard-dose or reduced-dose tacrolimus in liver transplant recipients.
MLA
Nashan, Björn, et al. “Pharmacokinetics, Efficacy, and Safety of Mycophenolate Mofetil in Combination with Standard-Dose or Reduced-Dose Tacrolimus in Liver Transplant Recipients.” Liver Transplantation, vol. 15, no. 2, Feb. 2009, pp. 136–47. EBSCOhost, https://doi.org/10.1002/lt.21657.
APA
Nashan, B., Saliba, F., Durand, F., Barcéna, R., Herrero, J. I., Mentha, G., Neuhaus, P., Bowles, M., Patch, D., Bernardos, A., Klempnauer, J., Bouw, R., Ives, J., Mamelok, R., McKay, D., Truman, M., & Marotta, P. (2009). Pharmacokinetics, efficacy, and safety of mycophenolate mofetil in combination with standard-dose or reduced-dose tacrolimus in liver transplant recipients. Liver Transplantation, 15(2), 136–147. https://doi.org/10.1002/lt.21657
Chicago
Nashan, Björn, Faouzi Saliba, Francois Durand, Rafael Barcéna, Jose Ignacio Herrero, Gilles Mentha, Peter Neuhaus, et al. 2009. “Pharmacokinetics, Efficacy, and Safety of Mycophenolate Mofetil in Combination with Standard-Dose or Reduced-Dose Tacrolimus in Liver Transplant Recipients.” Liver Transplantation 15 (2): 136–47. doi:10.1002/lt.21657.